Track insider buy and sell

Home

ATCT - As of 06/24/24, 01:50:25 AM: 40 Insider Transactions. Sector: Unknown Industry: Information Technology Services Prev Close:$0.00 Avg Vol(3m): 2,286 P/E: 0.00 EPS: 0.00 Email this page to a friend. Insider Transactions for ATCT

Buy/Sell*	Filed Date	Subject	Symbol	Acquirer	Pct Owned	Details
B	2012-05-02 08:59:45.0	ATS CORP	ATSC	Carl Marks & Co	100.0%	view
B	2012-04-03 16:38:04.0	ATS CORP	ATSC	LC CAPITAL MASTER FUND LTD	14.0%	view
S	2012-04-02 16:12:24.0	ATS CORP	ATSC	JACKS JOEL R	n/a	view
S	2012-04-02 10:52:31.0	ATS CORP	ATSC	GAMCO INVESTORS	0.0%	view
B	2012-03-16 10:53:18.0	ATS CORP	ATSC	GAMCO INVESTORS	4.29%	view
B	2012-03-14 16:31:48.0	ATS CORP	ATSC	GAMCO INVESTORS	2.57%	view
S	2012-03-05 10:19:57.0	ATS CORP	ATSC	Carl Marks & Co	14.21%	view
S	2012-03-02 18:19:55.0	ATS CORP	ATSC	LC CAPITAL MASTER FUND LTD	10.1%	view
S	2012-02-29 17:23:19.0	ATS CORP	ATSC	Revelation Special Situations Fund Ltd	21.72%	view
B	2012-02-24 15:31:57.0	ATS CORP	ATSC	LC CAPITAL MASTER FUND LTD	21.0%	view
S	2012-02-22 10:53:46.0	ATS CORP	ATSC	JACKS JOEL R	6.0%	view
B	2012-02-14 14:23:26.0	ATS CORP	ATSC	Minerva Advisors LLC	8.8%	view
S	2012-02-13 14:46:23.0	ATS CORP	ATSC	ATHENA CAPITAL MANAGEMENT INC	n/a	view
B	2011-10-05 11:23:39.0	ATS CORP	ATSC	Revelation Special Situations Fund Ltd	21.73%	view
B	2011-07-01 14:39:41.0	ATS CORP	ATSC	JACKS JOEL R	6.1%	view
S	2011-02-14 19:17:55.0	ATS CORP	ATSC	LC CAPITAL MASTER FUND LTD	21.0%	view
B	2011-02-11 16:35:46.0	ATS CORP	ATSC	Osmium Special Situations Fund Ltd	21.08%	view
B	2010-12-14 15:19:56.0	ATS CORP	ATSC	Carl Marks & Co	14.64%	view
S	2010-10-25 14:35:23.0	Protagonist Therapeutics	PTGX	BlackRock Inc	4.8%	view
S	2020-06-08 16:04:49.0	Protagonist Therapeutics	PTGX	Lilly Ventures Fund I LLC	4.5%	view
S	2020-05-22 16:30:49.0	Protagonist Therapeutics	PTGX	Venrock Healthcare Capital Partners II	0.4%	view
S	2020-02-14 16:00:33.0	Protagonist Therapeutics	PTGX	BIOTECHNOLOGY VALUE FUND L P	8.1%	view
B	2020-02-14 13:24:46.0	Protagonist Therapeutics	PTGX	RTW INVESTMENTS	9.9%	view
B	2020-02-07 11:28:22.0	Protagonist Therapeutics	PTGX	FMR LLC	14.999%	view
B	2020-02-07 08:45:16.0	Protagonist Therapeutics	PTGX	BlackRock Inc	5.7%	view
B	2019-07-01 16:49:53.0	Protagonist Therapeutics	PTGX	INTEGRATED CORE STRATEGIES	3.5%	view
S	2019-02-14 16:34:41.0	Protagonist Therapeutics	PTGX	GREAT POINT PARTNERS LLC	9.99%	view
S	2019-02-13 21:12:16.0	Protagonist Therapeutics	PTGX	ADAGE CAPITAL PARTNERS GP	0.0%	view
S	2019-02-13 12:02:31.0	Protagonist Therapeutics	PTGX	Aisling Capital IV	n/a	view
B	2019-01-24 13:09:04.0	Protagonist Therapeutics	PTGX	PERCEPTIVE ADVISORS LLC	5.3%	view
B	2018-08-17 17:40:34.0	Protagonist Therapeutics	PTGX	FARALLON CAPITAL MANAGEMENT LLC	10.9%	view
B	2018-07-02 16:04:26.0	Protagonist Therapeutics	PTGX	GREAT POINT PARTNERS LLC	6.9%	view
B	2018-02-20 18:49:32.0	Protagonist Therapeutics	PTGX	FMR LLC	14.999%	view
S	2018-02-07 16:23:21.0	Protagonist Therapeutics	PTGX	ADAGE CAPITAL PARTNERS GP	9.7%	view
S	2017-06-01 16:09:01.0	Protagonist Therapeutics	PTGX	RA CAPITAL MANAGEMENT	4.1%	view
B	2017-02-14 11:45:16.0	Protagonist Therapeutics	PTGX	FMR LLC	10.37%	view
B	2017-02-09 13:25:21.0	Protagonist Therapeutics	PTGX	ADAGE CAPITAL PARTNERS GP	9.16%	view
B	2016-10-11 13:49:13.0	Protagonist Therapeutics	PTGX	FMR LLC	5.1%	view
B	2016-08-26 16:09:57.0	Protagonist Therapeutics	PTGX	Lilly Ventures Fund I LLC	6.8%	view
B	2016-08-19 11:44:19.0	Protagonist Therapeutics	PTGX	ADAGE CAPITAL PARTNERS GP	9.69%	view

* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.